Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Humanin vs MOTS-c
An educational, source-based comparison of Humanin and MOTS-c — how each peptide works, what it's researched for, and what to know before going deeper.
Mitochondrial-derived peptide studied for neuroprotection and metabolism.
A 24-amino-acid peptide encoded in mitochondrial DNA. Research suggests cytoprotective effects against Alzheimer's-related toxicity, improved insulin sensitivity, and modulation of apoptotic signaling.
- Neuroprotection (Alzheimer's models)
- Insulin sensitivity
- Cardiovascular protection in animal models
- • Early-stage research.
- • No approved therapeutic use.
A 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. Research suggests it activates AMPK, enhances insulin sensitivity, and regulates nuclear gene expression in response to metabolic stress — positioning it as a candidate mitochondrial-nuclear signaling peptide.
- Insulin sensitivity
- Exercise capacity and mitochondrial biogenesis
- Age-related metabolic decline
- Obesity models
- • Early-stage research; no approved human therapeutic use.
- • Long-term effects unknown.
Humanin vs MOTS-c — Key differences
- Class: Humanin is classified as Mitochondrial · Neuroprotection, while MOTS-c is Mitochondrial · Metabolic.
- Primary research focus: Humanin — neuroprotection (alzheimer's models); MOTS-c — insulin sensitivity.
- Tag: Longevity vs Longevity.